Eye Care - Bosnia and Herzegovina

  • Bosnia and Herzegovina
  • In Bosnia and Herzegovina, the revenue in the Eye Care market market in 2024 is estimated to be US$3.07m.
  • It is projected to experience an annual growth rate of 3.97% (CAGR 2024-2029).
  • When compared globally, the in the United States generates the highest revenue in this market, reaching US$1,256.00m in 2024.
  • In terms of per capita revenues, each individual in Bosnia and Herzegovina generates US$0.96 in 2024.
  • Bosnia and Herzegovina is witnessing a growing trend in the Eye Care OTC Pharmaceuticals market, with an increasing demand for innovative products and a rise in awareness about the importance of eye health.

Key regions: Australia, Japan, Brazil, United States, Europe

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Eye Care market in Bosnia and Herzegovina is experiencing steady growth due to increasing customer preferences for vision correction and the rising prevalence of eye-related disorders. Customer preferences in the Eye Care market in Bosnia and Herzegovina are shifting towards a greater emphasis on vision correction. With the increasing use of digital devices and prolonged screen time, many individuals are experiencing eye strain and other vision problems. As a result, there is a growing demand for eyeglasses, contact lenses, and other vision correction products. Additionally, there is a rising awareness about the importance of regular eye check-ups and preventive measures to maintain optimal eye health. Trends in the market indicate a growing demand for innovative and technologically advanced eye care products. Customers are seeking products that offer enhanced comfort, improved vision, and convenience. For example, there is a rising demand for contact lenses with features such as UV protection, moisture retention, and extended wear. Furthermore, there is a growing interest in products that cater to specific eye conditions, such as dry eyes or astigmatism. This trend is driving manufacturers to invest in research and development to introduce new and improved eye care products to the market.Local special circumstances in Bosnia and Herzegovina play a role in the development of the Eye Care market. The country has a relatively high prevalence of eye-related disorders, such as myopia and cataracts. This can be attributed to various factors, including genetic predisposition, lifestyle choices, and environmental factors. As a result, there is a higher demand for eye care products and services in the market. Additionally, the country's aging population is also contributing to the growth of the market, as older individuals are more prone to age-related eye conditions and require specialized eye care.Underlying macroeconomic factors, such as increasing disposable income and improved healthcare infrastructure, are also driving the growth of the Eye Care market in Bosnia and Herzegovina. As the economy continues to grow, individuals have more purchasing power to invest in eye care products and services. Furthermore, the expansion of healthcare facilities and the availability of specialized eye care professionals have made eye care more accessible to the general population. This has resulted in increased awareness and utilization of eye care services, further fueling the growth of the market.In conclusion, the Eye Care market in Bosnia and Herzegovina is developing due to increasing customer preferences for vision correction, the rising prevalence of eye-related disorders, and the influence of local special circumstances. The market is witnessing a shift towards a greater emphasis on vision correction and a growing demand for innovative and technologically advanced eye care products. Factors such as the high prevalence of eye-related disorders, the aging population, increasing disposable income, and improved healthcare infrastructure are contributing to the growth of the market.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)